Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Multicomponent reaction for the synthesis of new 1,3,4-thiadiazole-thiazolidine-4-one molecular hybrids as promising antidiabetic agents through α-glucosidase and α-amylase inhibition
Lalitha Gummidi, Nagaraju Kerru, Oluwakemi Ebenezer, et al.
Bioorganic Chemistry (2021) Vol. 115, pp. 105210-105210
Closed Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

The α-Amylase and α-Glucosidase Inhibition Capacity of Grape Pomace: A Review
Miluska Cisneros‐Yupanqui, Anna Lante, Dasha Mihaylova, et al.
Food and Bioprocess Technology (2022) Vol. 16, Iss. 4, pp. 691-703
Open Access | Times Cited: 45
In silico and in vitro prediction of new synthesized N-heterocyclic compounds as anti-SARS-CoV-2
Heba E. Hashem, Sajjad Ahmad, Ajoy Kumer, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 11
Design, synthesis, molecular dynamic simulation, DFT analysis, computational pharmacology and decoding the antidiabetic molecular mechanism of sulphonamide-thiazolidin-4-one hybrids
Shriram D. Ranade, Shankar G. Alegaon, Nayeem A. Khatib, et al.
Journal of Molecular Structure (2024) Vol. 1311, pp. 138359-138359
Closed Access | Times Cited: 7
Design, synthesis, in-vitro and in-silico studies of 6-bromochromone based thiosemicarbazones as α-glucosidase inhibitors
Kholood A. Dahlous, Muhammad Ajmal, Naeem Ullah, et al.
Journal of Molecular Structure (2025), pp. 141374-141374
Closed Access
Synthesis of Novel 2,3-Dihydro-1,5-Benzothiazepines as α-Glucosidase Inhibitors: In Vitro, In Vivo, Kinetic, SAR, Molecular Docking, and QSAR Studies
Rabia Mehmood, Ehsan Ullah Mughal, Eslam B. Elkaeed, et al.
ACS Omega (2022) Vol. 7, Iss. 34, pp. 30215-30232
Open Access | Times Cited: 30
Synthesis, in-vitro α-glucosidase inhibition and molecular docking studies of 1,3,4-thiadiazole-5,6-diphenyl-1,2,4-triazine hybrids: Potential leads in the search of new antidiabetic drugs
Hariom Kumar, Manoj Dhameja, Sirisha Kurella, et al.
Journal of Molecular Structure (2022) Vol. 1273, pp. 134339-134339
Closed Access | Times Cited: 29
Recent Studies of Nitrogen and Sulfur Containing Heterocyclic Analogues as Novel Antidiabetic Agents: A Review
Shankar Gharge, Shankar G. Alegaon
Chemistry & Biodiversity (2023) Vol. 21, Iss. 2
Closed Access | Times Cited: 15
New 1,3,4-Thiadiazole Derivatives as α-Glucosidase Inhibitors: Design, Synthesis, DFT, ADME, and In Vitro Enzymatic Studies
Zahid Ali, Wajid Rehman, Liaqat Rasheed, et al.
ACS Omega (2024)
Open Access | Times Cited: 4
Novel molecular hybrids of EGCG and quinoxaline: Potent multi-targeting antidiabetic agents that inhibit α-glucosidase, α-amylase, and oxidative stress
Manan Kothari, K. K. Kannan, Revathy Sahadevan, et al.
International Journal of Biological Macromolecules (2024) Vol. 263, pp. 130175-130175
Closed Access | Times Cited: 4
Thiazolidinone‐Heterocycle Frameworks: A Concise Review of Their Pharmacological Significance
Pule Seboletswe, Nosipho Cele, Parvesh Singh
ChemMedChem (2023) Vol. 18, Iss. 7
Closed Access | Times Cited: 11
Antidiabetic potential of thiazolidinedione derivatives with efficient design, molecular docking, structural activity relationship, and biological activity: an update review (2021–2023)
Anchal Sharma, Nitish Kumar, Harmandeep Kaur Gulati, et al.
Molecular Diversity (2024)
Closed Access | Times Cited: 3
Effective α-glycosidase inhibitors based on polyphenolic benzothiazole heterocycles
Esra Sevimli, Gökçe Seyhan, Didem Akkaya, et al.
Bioorganic Chemistry (2024) Vol. 147, pp. 107366-107366
Closed Access | Times Cited: 3
Towards Covid-19 TMPRSS2 enzyme inhibitors and antimicrobial agents: Synthesis, antimicrobial potency, molecular docking, and drug-likeness prediction of thiadiazole-triazole hybrids
Huda R. M. Rashdan, Aboubakr H. Abdelmonsef
Journal of Molecular Structure (2022) Vol. 1268, pp. 133659-133659
Open Access | Times Cited: 18
Synthesis, in vitro biological analysis and molecular docking studies of new thiadiazole-based thiourea derivatives as dual inhibitors of a-amylase and a-glucosidase
Imran Khan, Wajid Rehman, Fazal Rahim, et al.
Arabian Journal of Chemistry (2023) Vol. 16, Iss. 9, pp. 105078-105078
Open Access | Times Cited: 10
Unveiling the chemistry of 1,3,4‐oxadiazoles and thiadiazols: A comprehensive review
Vivek Kumar Gour, Shaikh Yahya, Mohammad Shahar Yar
Archiv der Pharmazie (2023) Vol. 357, Iss. 1
Open Access | Times Cited: 9
Discovery of Novel and Selective Schiff Base Inhibitors as a Key for Drug Synthesis, Molecular Docking, and Pharmacological Evaluation
Imran Khan, Wajid Rehman, Liaqat Rasheed, et al.
ACS Omega (2024) Vol. 9, Iss. 28, pp. 31148-31158
Open Access | Times Cited: 2
Advancing drug discovery: Thiadiazole derivatives as multifaceted agents in medicinal chemistry and pharmacology
Benjamin Ayodipupo Babalola, Lekhnath Sharma, Olanike G. Olowokere, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 112, pp. 117876-117876
Closed Access | Times Cited: 2
Design, synthesis, spectroscopic characterization, computational analysis, and in vitro α-amylase and α-glucosidase evaluation of 3-aminopyridin-2(1H)-one based novel monothiooxamides and 1,3,4-thiadiazoles
Ирина В. Паламарчук, Zarina Shulgau, Adilet Y. Dautov, et al.
Organic & Biomolecular Chemistry (2022) Vol. 20, Iss. 45, pp. 8962-8976
Closed Access | Times Cited: 12
Synthesis and application of novel urea–benzoic acid functionalized magnetic nanoparticles for the synthesis of 2,3-disubstituted thiazolidin-4-ones and hexahydroquinolines
Fazlulhaq Fazl, Morteza Torabi, Meysam Yarie, et al.
RSC Advances (2022) Vol. 12, Iss. 26, pp. 16342-16353
Open Access | Times Cited: 11
Synthetic strategies and medicinal perspectives of 4‐thiazolidinones: Recent developments and structure–activity relationship studies
Pooja A. Chawla, Simranpreet K. Wahan, Meenakshi Negi, et al.
Journal of Heterocyclic Chemistry (2022) Vol. 60, Iss. 8, pp. 1248-1286
Closed Access | Times Cited: 9
Synthesis, characterization, crystallographic, binding, in silico and antidiabetic studies of novel 2,4-thiazolidinedione-phenothiazine molecular hybrids
Manasa A. Doddagaddavalli, Veerendra Kumar A. Kalalbandi, J. Seetharamappa
Journal of Molecular Structure (2022) Vol. 1276, pp. 134625-134625
Closed Access | Times Cited: 9
Anti-diabetic potential of Chamaerops humilis L. aerial parts: phenolic compounds with α-amylase and α-glucosidase inhibitory activates in-vitro, in-vivo and in-silico studies
Marian Nabil, Iman A.A. Kassem, Neveen S. Ghaly, et al.
Journal of Molecular Structure (2024) Vol. 1312, pp. 138550-138550
Closed Access | Times Cited: 1
Ultrasound-assisted synthesis of 4-thiazolidinone Schiff bases and their antioxidant, α-glucosidase, α-amylase inhibition, mode of inhibition and computational studies
Pule Seboletswe, Gobind Kumar, Lungisani Kubone, et al.
Medicinal Chemistry Research (2024) Vol. 33, Iss. 9, pp. 1578-1597
Open Access | Times Cited: 1
Synthesis, Properties, and Biological Applications of 1,3,4-Thiadiazoles
Kalyani Sonawane, Rushikesh Said, Navnath T. Hatvate
Royal Society of Chemistry eBooks (2024), pp. 163-223
Closed Access | Times Cited: 1
Exploring the Antimicrobial and Antitubercular Potential of 1-Thia-4-azaspiro[4.5]decan-3-one Derivatives: Synthesis, Molecular Docking, and MD Simulations
Parth P. Patel, Navin B. Patel, Manesh S. Tople, et al.
Journal of Molecular Structure (2024), pp. 141107-141107
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top